Pharmacokinetic considerations for the treatment of diabetes in patients with chronic kidney disease

MEDICATIONS IN THE KIDNEY

(2014) A.J. Scheen   ACTA CLINICA BELGICA

Efficacy and safety of Jentadueto® (linagliptin plus metformin)

(2013) André J Scheen   Expert Opinion On Drug Safety

KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update

(2012)   AMERICAN JOURNAL OF KIDNEY DISEASES

Management of Hyperglycemia, Dyslipidemia, and Albuminuria in Patients With Diabetes and CKD: A Systematic Review for a KDOQI Clinical Practice Guideline

(2012) Yelena Slinin et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Clinical Pharmacokinetics and Pharmacodynamics of Vildagliptin

(2012) Yan-Ling He   CLINICAL PHARMACOKINETICS

Comparative Clinical Pharmacokinetics of Dipeptidyl Peptidase-4 Inhibitors

(2012) Larry K. Golightly et al.   CLINICAL PHARMACOKINETICS

The Effect of Novel Promoter Variants in MATE1 and MATE2 on the Pharmacokinetics and Pharmacodynamics of Metformin

(2012) S L Stocker et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Chronic kidney disease in type 2 diabetes patients in France: Prevalence, influence of glycaemic control and implications for the pharmacological management of diabetes

(2012) B. Detournay et al.   DIABETES & METABOLISM

A Randomized Trial of Two Weight-Based Doses of Insulin Glargine and Glulisine in Hospitalized Subjects With Type 2 Diabetes and Renal Insufficiency

(2012) D. Baldwin et al.   DIABETES CARE

Long-Term Efficacy and Safety of Linagliptin in Patients With Type 2 Diabetes and Severe Renal Impairment: A 1-year, randomized, double-blind, placebo-controlled study

(2012) J. B. McGill et al.   DIABETES CARE

One-year safety, tolerability and efficacy of vildagliptin in patients with type 2 diabetes and moderate or severe renal impairment

(2012) W. Kothny et al.   DIABETES OBESITY & METABOLISM

Metformin therapy in patients with chronic kidney disease

(2012) J. K. Duong et al.   DIABETES OBESITY & METABOLISM

Exenatide and sitagliptin are not associated with increased risk of acute renal failure: a retrospective claims analysis

(2012) M. Pendergrass et al.   DIABETES OBESITY & METABOLISM

Outcomes and lessons from the PROactive study

(2012) André J. Scheen   DIABETES RESEARCH AND CLINICAL PRACTICE

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

(2012) S. E. Inzucchi et al.   DIABETOLOGIA

Dapagliflozin

(2012) Greg L. Plosker   DRUGS

Repaglinide

(2012) Lesley J. Scott   DRUGS

Saxagliptin plus metformin combination in patients with type 2 diabetes and renal impairment

(2012) André J Scheen   Expert Opinion on Drug Metabolism & Toxicology

Drug-induced hypoglycaemia in type 2 diabetes

(2012) Berit Inkster et al.   Expert Opinion On Drug Safety

Pharmacokinetics of empagliflozin, a sodium glucose cotransporter-2 (SGLT2) inhibitor, and metformin following co-administration in healthy volunteers

(2012) Sreeraj Macha et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Metformin in patients with chronic kidney disease: strengths and weaknesses

(2012) Ana Rocha et al.   JOURNAL OF NEPHROLOGY

Comparative effectiveness of incident oral antidiabetic drugs on kidney function

(2012) Adriana M. Hung et al.   KIDNEY INTERNATIONAL

Liraglutide-Induced Acute Kidney Injury

(2012) Yaman Kaakeh et al.   PHARMACOTHERAPY

Use of Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease

(2012) Nasser Mikhail   POSTGRADUATE MEDICINE

Intervention to Decrease Glyburide Use in Elderly Patients With Renal Insufficiency

(2011) Sherrie L. Aspinall et al.   American Journal Geriatric Pharmacotherapy

Influence of Renal or Hepatic Impairment on the Pharmacokinetics of Saxagliptin

(2011) David W. Boulton et al.   CLINICAL PHARMACOKINETICS

Clinical Pharmacokinetics of Metformin

(2011) Garry G. Graham et al.   CLINICAL PHARMACOKINETICS

Antidiabetic Agents in Patients with Chronic Kidney Disease and End-Stage Renal Disease on Dialysis: Metabolism and Clinical Practice

(2011) Masanori Abe et al.   CURRENT DRUG METABOLISM

Inherited Variation in Vitamin D Genes Is Associated With Predisposition to Autoimmune Disease Type 1 Diabetes

(2011) J. D. Cooper et al.   DIABETES

Estimation of renal function in patients with diabetes

(2011) V. Rigalleau et al.   DIABETES & METABOLISM

Limitations and Future Treatment Options in Type 2 Diabetes With Renal Impairment

(2011) E. Ritz   DIABETES CARE

Use of Metformin in the Setting of Mild-to-Moderate Renal Insufficiency

(2011) K. J. Lipska et al.   DIABETES CARE

Effect of renal impairment on the pharmacokinetics of the dipeptidyl peptidase-4 inhibitor linagliptin*

(2011) U. Graefe-Mody et al.   DIABETES OBESITY & METABOLISM

Saxagliptin improves glycaemic control and is well tolerated in patients with type 2 diabetes mellitus and renal impairment

(2011) M. Nowicki et al.   DIABETES OBESITY & METABOLISM

Safety and efficacy of vildagliptin versus placebo in patients with type 2 diabetes and moderate or severe renal impairment: a prospective 24-week randomized placebo-controlled trial

(2011) V. Lukashevich et al.   DIABETES OBESITY & METABOLISM

Metformin-associated lactic acidosis following acute kidney injury. Efficacious treatment with continuous renal replacement therapy

(2011) S. Dichtwald et al.   DIABETIC MEDICINE

The dipeptidyl peptidase-4 (DPP-4) inhibitor vildagliptin improves glycemic control in type 2 diabetic patients undergoing hemodialysis

(2011) Midori Ito et al.   ENDOCRINE JOURNAL

Linagliptin for the treatment of type 2 diabetes (pharmacokinetic evaluation)

(2011) André J Scheen   Expert Opinion on Drug Metabolism & Toxicology

The safety of thiazolidinediones

(2011) Keith G Tolman   Expert Opinion On Drug Safety

A review of gliptins in 2011

(2011) André J Scheen   EXPERT OPINION ON PHARMACOTHERAPY

Long-term treatment with the dipeptidyl peptidase-4 inhibitor saxagliptin in patients with type 2 diabetes mellitus and renal impairment: a randomised controlled 52-week efficacy and safety study

(2011) M. Nowicki et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Temporal Trends in the Prevalence of Diabetic Kidney Disease in the United States

(2011) Ian H. de Boer   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Evaluation of Modification of Diet in Renal Disease study and Cockcroft-Gault equations for sitagliptin dosing

(2011) M. Shawn McFarland et al.   JOURNAL OF NEPHROLOGY

Metformin: The Safest Hypoglycaemic Agent in Chronic Kidney Disease?

(2011) Helen J. Nye et al.   NEPHRON CLINICAL PRACTICE

Type 2 Diabetes Mellitus and Renal Impairment in a Large Outpatient Electronic Medical Records Database: Rates of Diagnosis and Antihyperglycemic Medication Dose Adjustment

(2011) Juliana L. Meyers et al.   POSTGRADUATE MEDICINE

Pharmacologic management of the older patient with type 2 diabetes mellitus

(2010) Joshua J. Neumiller et al.   American Journal Geriatric Pharmacotherapy

Metformin Use and Mortality Among Patients With Diabetes and AtherothrombosisMetformin Use With Diabetes and Atherothrombosis

(2010) Ronan Roussel   ARCHIVES OF INTERNAL MEDICINE

Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States

(2010) Carol E. Koro et al.   CLINICAL THERAPEUTICS

Novel Assay of Metformin Levels in Patients With Type 2 Diabetes and Varying Levels of Renal Function: Clinical recommendations

(2010) A. Frid et al.   DIABETES CARE

Pharmacokinetics of dipeptidylpeptidase-4 inhibitors

(2010) A. J. Scheen   DIABETES OBESITY & METABOLISM

Limitations of metformin use in patients with kidney disease: are they warranted?

(2010) K. P. Vasisht et al.   DIABETES OBESITY & METABOLISM

An assessment of adverse effects of vildagliptin versus comparators on the liver, the pancreas, the immune system, the skin and in patients with impaired renal function from a large pooled database of Phase II and III clinical trials

(2010) M. Ligueros-Saylan et al.   DIABETES OBESITY & METABOLISM

Safety and tolerability of vildagliptin vs. thiazolidinedione as add-on to metformin in type 2 diabetic patients with and without mild renal impairment: A retrospective analysis of the GALIANT study

(2010) M.A. Banerji et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Thiazolidinediones and fracture risk in patients with Type 2 diabetes

(2010) D. J. Betteridge   DIABETIC MEDICINE

Lactic Acidosis Induced by Metformin

(2010) Jean-Daniel Lalau   DRUG SAFETY

Sodium-Glucose Co-Transport Inhibitors

(2010) Joshua J. Neumiller et al.   DRUGS

Efficacy and safety of mitiglinide in diabetic patients on maintenance hemodialysis

(2010) Masanori Abe et al.   ENDOCRINE JOURNAL

Mild Renal Impairment and the Efficacy and Safety of Liraglutide

(2010) Jaime Davidson et al.   Endocrine Practice

Pharmacokinetic and pharmacodynamic evaluation of sitagliptin plus metformin

(2010) André J Scheen   Expert Opinion on Drug Metabolism & Toxicology

Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients

(2010) Andreas Holstein et al.   Expert Opinion On Drug Safety

Clinical effectiveness and safety evaluation of long-term pioglitazone treatment for erythropoietin responsiveness and insulin resistance in type 2 diabetic patients on hemodialysis

(2010) Masanori Abe et al.   EXPERT OPINION ON PHARMACOTHERAPY

Characteristics of Patients With Sulphonurea-Induced Hypoglycemia

(2010) Yael Dinur Schejter et al.   Journal of the American Medical Directors Association

Review: Metformin: Potential benefits and use in chronic kidney disease

(2010) HELEN L PILMORE   NEPHROLOGY

Impaired renal function modifies the risk of severe hypoglycaemia among users of insulin but not glyburide: a population-based nested case–control study

(2010) Matthew A. Weir et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Acute renal failure when exenatide is co-administered with diuretics and angiotensin II blockers

(2010) Alfonso López-Ruiz et al.   PHARMACY WORLD & SCIENCE

Selection and Dosing of Medications for Management of Diabetes in Patients with Advanced Kidney Disease

(2010) James B. Reilly et al.   SEMINARS IN DIALYSIS

Metformin use in renal dysfunction: Is a serum creatinine threshold appropriate?

(2009) A. M. Philbrick et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Diabetes Mellitus and CKD Awareness: The Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES)

(2009) Adam Whaley-Connell et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Effect of renal impairment on the pharmacokinetics of the GLP-1 analogue liraglutide

(2009) Lisbeth V. Jacobsen et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Frequency of Hypoglycemia and Its Significance in Chronic Kidney Disease

(2009) M. F. Moen et al.   Clinical Journal of the American Society of Nephrology

The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of Metformin

(2009) M V Tzvetkov et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Exenatide-Associated Ischemic Renal Failure

(2009) W. J. Weise et al.   DIABETES CARE

Combination therapy with mitiglinide and voglibose improves glycemic control in type 2 diabetic patients on hemodialysis

(2009) Masanori Abe et al.   EXPERT OPINION ON PHARMACOTHERAPY

Rosiglitazone Is Associated with Mortality in Chronic Hemodialysis Patients

(2009) S. P.B. Ramirez et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Thiazolidinedione use is associated with better survival in hemodialysis patients with non-insulin dependent diabetes

(2009) Steven M. Brunelli et al.   KIDNEY INTERNATIONAL

Prescribing metformin in type 2 diabetes with a contraindication: prevalence and outcome

(2009) Juraporn Pongwecharak et al.   PHARMACY WORLD & SCIENCE

Management of Diabetes in Patients with Chronic Kidney Disease

(2009) Ziauddin Ahmed et al.   POSTGRADUATE MEDICINE

Plasma Concentration of Pioglitazone in Patients With Type 2 Diabetes on Hemodialysis

(2009)   THERAPEUTIC APHERESIS AND DIALYSIS

Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency

(2008) J. C. N. Chan et al.   DIABETES OBESITY & METABOLISM

Pharmacokinetics of single-dose rosiglitazone in chronic ambulatory peritoneal dialysis patients

(2008) P. Aramwit et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Which hypoglycaemic agents to use in type 2 diabetic subjects with CKD and how?

(2008) M. Haneda et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Paget's Disease of the Mandible

(2008) Mayank B. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Pioglitazone on Cardiovascular Outcome in Diabetes and Chronic Kidney Disease

(2007) C. A. Schneider et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY